We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$127B
1-Year Est. Return
44.11%
This Fund
S&P 500
This Quarter
Est. Return
+12.35%
1 Year Est. Return
+44.11%
3 Year Est. Return
+121.64%
5 Year Est. Return
+154.22%
10 Year Est. Return
+724.54%
AUM
$136B
AUM Growth
+$12.5B
(+10%)
Cap. Flow
-$1.5B
Cap. Flow
% of AUM
-1.11%
Top 10 Holdings %
Top 10 Hldgs %
28.12%
Holding
295
New
4
Increased
72
Reduced
149
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elanco Animal Health
ELAN
|
+$789M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$158M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$91.7M |
| 4 |
CVS Health
CVS
|
+$88.1M |
| 5 |
Novartis
NVS
|
+$86.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$896M |
| 2 |
NVIDIA
NVDA
|
+$256M |
| 3 |
Amgen
AMGN
|
+$155M |
| 4 |
Cisco
CSCO
|
+$138M |
| 5 |
Adobe
ADBE
|
+$131M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.33% |
| 2 | Healthcare | 24.5% |
| 3 | Industrials | 15.11% |
| 4 | Consumer Discretionary | 9.46% |
| 5 | Financials | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Eli Lilly
LLY
$1.07T
| $5.61B | 4.13% |
43,237,704
-7,365,752
| -15% | -$896M |
|
|
2
Adobe
ADBE
$89.5B
| $5.15B | 3.79% |
19,328,193
-521,487
| -3% | -$131M |
|
3
Microsoft
MSFT
$2.84T
| $4.46B | 3.29% |
37,858,167
-793,006
| -2% | -$86.5M |
|
4
Southwest Airlines
LUV
$22.1B
| $3.82B | 2.81% |
73,653,477
-106,706
| -0.1% | -$5.63M |
|
|
5
Amgen
AMGN
$203B
| $3.62B | 2.66% |
19,032,868
-813,348
| -4% | -$155M |
|
6
Texas Instruments
TXN
$255B
| $3.54B | 2.6% |
33,361,569
-253,606
| -0.8% | -$26.3M |
|
7
Biogen
BIIB
$29.9B
| $3.45B | 2.54% |
14,586,382
-129,835
| -0.9% | -$40.9M |
|
8
United Airlines
UAL
$38.4B
| $3.05B | 2.24% |
38,205,624
-52,353
| -0.1% | -$4.42M |
|
9
Alibaba
BABA
$269B
| $2.78B | 2.05% |
15,253,040
-14,090
| -0.1% | -$2.37M |
|
10
FedEx
FDX
$74.5B
| $2.73B | 2.01% |
15,050,770
-9,912
| -0.1% | -$1.75M |
|
11
Alphabet (Google) Class A
GOOGL
$3.91T
| $2.58B | 1.9% |
43,925,560
+39,700
| +0.1% | +$2.24M |
|
|
12
Alphabet (Google) Class C
GOOG
$3.9T
| $2.49B | 1.83% |
42,411,460
-48,600
| -0.1% | -$2.73M |
|
13
Micron Technology
MU
$1.04T
| $2.39B | 1.76% |
57,796,235
-68,650
| -0.1% | -$2.65M |
|
14
NetApp
NTAP
$32.9B
| $2.35B | 1.73% |
33,917,978
-1,513,400
| -4% | -$97.7M |
|
15
JPMorgan Chase
JPM
$939B
| $2.35B | 1.73% |
23,166,378
+11,100
| +0% | +$1.14M |
|
|
16
Novartis
NVS
$295B
| $2.29B | 1.69% |
26,624,653
+1,082,503
| +4% | +$86.9M |
|
17
AstraZeneca
AZN
$263B
| $2.28B | 1.68% |
28,171,578
+97,615
| +0.3% | +$7.69M |
|
18
Wells Fargo
WFC
$261B
| $2.22B | 1.63% |
45,964,686
+495,907
| +1% | +$24.4M |
|
19
American Airlines Group
AAL
$9.58B
| $2.19B | 1.61% |
68,835,752
-69,229
| -0.1% | -$2.33M |
|
20
Sony
SONY
$123B
| $1.76B | 1.29% |
208,191,100
-725,920
| -0.3% | -$6.8M |
|
21
Boston Scientific
BSX
$65.8B
| $1.73B | 1.27% |
45,054,777
-8,000
| -0% | -$306K |
|
22
Delta Air Lines
DAL
$55.9B
| $1.47B | 1.08% |
28,428,183
-26,843
| -0.1% | -$1.33M |
|
23
Hewlett Packard
HPE
$63.2B
| $1.42B | 1.04% |
91,923,218
-415,667
| -0.5% | -$6.41M |
|
24
Qualcomm
QCOM
$176B
| $1.4B | 1.03% |
24,633,445
+633,123
| +3% | +$34.2M |
|
25
KLA
KLAC
$275B
| $1.4B | 1.03% |
117,394,800
-4,981,810
| -4% | -$53.6M |
|
Similar funds
Primecap Management's Q1 2019 Portfolio in Review
As of Q1 2019, Primecap Management held 295 positions worth $136B, up 10% from $123B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2019: portfolio turnover was 2%. Primecap Management opened 4 new positions and exited 2, leaving the 295-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2019 buy was Lyft: 500,000 shares worth $39.1M.
- Primecap Management added most to Elanco Animal Health in Q1 2019, an estimated $789M increase.
- Primecap Management's biggest Q1 2019 reduction was Eli Lilly, cutting an estimated $896M.
- Primecap Management fully exited MINDBODY, Inc. Class A Common Stock in Q1 2019, selling an estimated $5.84M.
- Primecap Management's ten largest holdings make up 28% of its $136B portfolio in Q1 2019.
- Primecap Management opened 4 new positions and closed 2 in Q1 2019.
- Primecap Management's portfolio value rose 10% quarter-over-quarter to $136B.
Based on Primecap Management's 13F filing for Q1 2019, filed 14 May 2019.